Benefits Think How to manage the multimorbidity and costs of MSK pain

Published 8 Min Read

stock.adobe

If we want to move the needle on healthcare costs, we need to start with a key driver of those expenses: musculoskeletal (MSK) pain and dysfunction.

While many advisers and plan sponsors have implemented population health strategies that target metabolic syndrome and diabetes, a PBM solution or mental health, all require significant financial investments that can yield tepid results.

Mark Testa
Executive vice president

Mark Testa is the executive vice president of Regenexx for Business


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form